Covered recipient · General Payments record
MICHAEL BANOV
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2025 · Entire year
$158,399.73
287 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2025 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $90,592.29 | 27 |
| Honoraria | $49,089.00 | 14 |
| Travel and Lodging | $7,986.25 | 54 |
| Food and Beverage | $5,732.19 | 190 |
| Consulting Fee | $5,000.00 | 2 |
By paying entity
PY2025 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Axsome Therapeutics, Inc. | $50,948.07 | 63 |
| Teva Pharmaceuticals USA, Inc. | $32,485.67 | 27 |
| Janssen Pharmaceuticals, Inc | $23,005.86 | 31 |
| Vanda Pharmaceuticals Inc. | $17,300.21 | 33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16,528.98 | 30 |
| ABBVIE INC. | $15,606.74 | 40 |
| E.R. Squibb & Sons, L.L.C. | $1,544.58 | 12 |
| Otsuka America Pharmaceutical, Inc. | $174.84 | 12 |
| Noven Therapeutics, LLC | $173.29 | 11 |
| Bausch Health US, LLC | $132.61 | 6 |
| Neurocrine BioSciences, Inc. | $102.70 | 3 |
| Lundbeck LLC | $91.16 | 4 |
| Tris Pharma Inc | $79.39 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $63.20 | 3 |
| ACADIA Pharmaceuticals Inc | $45.43 | 2 |
| Alkermes, Inc. | $29.39 | 1 |
| Collegium Pharmaceutical, Inc. | $21.82 | 1 |
| Corium, LLC | $18.99 | 1 |
| Almatica Pharma LLC | $17.23 | 1 |
| Neos Therapeutics, LP | $15.78 | 1 |
| Supernus Pharmaceuticals, Inc. | $13.79 | 1 |
Page 2 of 6; records 51–100 of 287 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
MICHAEL BANOV
NPI 1881771004 · CMS profile ID 311843
Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
MARIETTA, GA
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 2 of 6; records 51–100 of 287 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1881771004?year=2025&recipient=provider&page=2#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- MICHAEL BANOV, NPI 1881771004, CMS profile ID 311843. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 6; records 51–100 of 287 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1881771004?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
- APA 7
- IndustryPayments. (2026). MICHAEL BANOV, NPI 1881771004, CMS profile ID 311843. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 6; records 51–100 of 287 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1881771004?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
- Bluebook
- MICHAEL BANOV, NPI 1881771004, CMS profile ID 311843, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 6; records 51–100 of 287 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1881771004?year=2025&recipient=provider&page=2#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30
287 matching records · $158,399.73 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 51–100 of 287.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | $2,475.00 | 10/15/2025 | Honoraria | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1235755859 | CMS |
| Axsome Therapeutics, Inc. | $24.50 | 10/15/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1235810188 | CMS |
| Alkermes, Inc. | $29.39 | 10/14/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1222441832 | CMS |
| ABBVIE INC. | $5.02 | 10/13/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1201469523 | CMS |
| ABBVIE INC. | $18.39 | 10/09/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1201469519 | CMS |
| ABBVIE INC. | $22.40 | 10/09/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1201469521 | CMS |
| E.R. Squibb & Sons, L.L.C. | $134.99 | 10/09/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1184665280 | CMS |
| E.R. Squibb & Sons, L.L.C. | $49.99 | 10/09/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1184665284 | CMS |
| E.R. Squibb & Sons, L.L.C. | $29.99 | 10/09/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1184665287 | CMS |
| E.R. Squibb & Sons, L.L.C. | $29.99 | 10/09/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1184665292 | CMS |
| E.R. Squibb & Sons, L.L.C. | $602.61 | 10/09/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1184665296 | CMS |
| E.R. Squibb & Sons, L.L.C. | $64.99 | 10/09/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1184665300 | CMS |
| E.R. Squibb & Sons, L.L.C. | $326.09 | 10/09/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1184665304 | CMS |
| E.R. Squibb & Sons, L.L.C. | $51.73 | 10/09/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1184665308 | CMS |
| Axsome Therapeutics, Inc. | $23.32 | 10/08/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1235542124 | CMS |
| ABBVIE INC. | $5.50 | 10/06/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1201469517 | CMS |
| Vanda Pharmaceuticals Inc. | $24.68 | 10/06/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1232946309 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $138.53 | 10/04/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1241253120 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24.29 | 10/04/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1241253122 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24.29 | 10/04/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1241253124 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $275.45 | 10/04/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1241253126 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $43.75 | 10/04/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1241253128 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $46.64 | 10/04/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1241253130 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $52.94 | 10/04/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1241253132 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $526.97 | 10/04/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1241253134 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $59.43 | 10/04/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1241253136 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $68.75 | 10/04/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1241253138 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26.87 | 10/01/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1241253118 | CMS |
| Tris Pharma Inc | $21.84 | 10/01/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1192255911 | CMS |
| ABBVIE INC. | $125.00 | 09/30/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1201469507 | CMS |
| ABBVIE INC. | $85.40 | 09/30/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1201469509 | CMS |
| ABBVIE INC. | $19.86 | 09/30/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1201469511 | CMS |
| ABBVIE INC. | $30.10 | 09/30/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1201469513 | CMS |
| ABBVIE INC. | $85.40 | 09/30/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1201469515 | CMS |
| ABBVIE INC. | $5.02 | 09/29/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1201469505 | CMS |
| Supernus Pharmaceuticals, Inc. | $13.79 | 09/29/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1244873821 | CMS |
| ABBVIE INC. | $21.78 | 09/25/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1201469501 | CMS |
| ABBVIE INC. | $43.40 | 09/25/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1201469503 | CMS |
| ACADIA Pharmaceuticals Inc | $22.38 | 09/18/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1247766257 | CMS |
| Vanda Pharmaceuticals Inc. | $25.69 | 09/17/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1232946304 | CMS |
| ABBVIE INC. | $2.37 | 09/15/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1201469499 | CMS |
| Collegium Pharmaceutical, Inc. | $21.82 | 09/15/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1224241246 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.24 | 09/10/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1247306145 | CMS |
| Vanda Pharmaceuticals Inc. | $0.89 | 09/10/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1232946277 | CMS |
| Vanda Pharmaceuticals Inc. | $119.55 | 09/10/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1232946281 | CMS |
| Vanda Pharmaceuticals Inc. | $2,600.00 | 09/10/2025 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1232946285 | CMS |
| Vanda Pharmaceuticals Inc. | $52.50 | 09/10/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1232946289 | CMS |
| Vanda Pharmaceuticals Inc. | $23.66 | 09/10/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1232946293 | CMS |
| Vanda Pharmaceuticals Inc. | $2,600.00 | 09/10/2025 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1232946297 | CMS |
| Vanda Pharmaceuticals Inc. | $72.10 | 09/10/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1232946300 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Principal investigator | $158,344.45 | 75 |
| PY2024 | Principal investigator | $202,575.94 | 78 |
| PY2023 | Principal investigator | $390,338.41 | 115 |
| PY2022 | Principal investigator | $396,019.30 | 118 |
| PY2021 | Principal investigator | $671,834.50 | 104 |
| PY2020 | Principal investigator | $1,069,472.33 | 92 |
| PY2019 | Recipient | $208,332.03 | 49 |
| PY2019 | Principal investigator | $584,103.07 | 84 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
75 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | ABBVIE INC. | $3,132.24 | 12/31/2025 | Non-covered Recipient Entity NORTHWEST BEHAVIORAL RESEARCH CENTER | A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study to Evaluate the Efficacy, Safety, and Tolerability of ABBV-932 as an Adjunct to Antidepressant Therapies in the Treatment of Subjects with Generalized Anxiety Disorder who have had an Inadequate Response to Antidepressant Therapies | No dispute reported | 06/30/2026 | 1202532733 |
| Principal investigator 1 | ABBVIE INC. | $4,439.61 | 12/31/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder | No dispute reported | 06/30/2026 | 1202535267 |
| Principal investigator 1 | ABBVIE INC. | $3,468.15 | 12/04/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder | No dispute reported | 06/30/2026 | 1202528026 |
| Principal investigator 1 | LivaNova USA, Inc. | $452.25 | 11/11/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545708 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 10/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545592 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 10/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545596 |
| Principal investigator 1 | LivaNova USA, Inc. | $452.25 | 10/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545600 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 10/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545655 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 10/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545659 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 10/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545663 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 10/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545667 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 09/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545587 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 09/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545651 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 08/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545575 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 08/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545579 |
| Principal investigator 1 | LivaNova USA, Inc. | $452.25 | 08/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545583 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 08/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545620 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 08/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545623 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 08/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545627 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 08/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545631 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 08/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545635 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 08/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545639 |
| Principal investigator 1 | LivaNova USA, Inc. | $452.25 | 08/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545643 |
| Principal investigator 1 | LivaNova USA, Inc. | $452.25 | 08/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545647 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,345.00 | 08/07/2025 | Non-covered Recipient Entity Advarra, Inc. (Central IRB) | RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression | No dispute reported | 06/30/2026 | 1245557012 |
| Principal investigator 1 | LivaNova USA, Inc. | $90.00 | 06/17/2025 | Non-covered Recipient Entity Advarra, Inc. (Central IRB) | RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression | No dispute reported | 06/30/2026 | 1245556664 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 06/10/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545433 |
| Principal investigator 1 | LivaNova USA, Inc. | $452.25 | 06/10/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545437 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 06/10/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545563 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 06/10/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545567 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 06/10/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545571 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 06/10/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545874 |
| Principal investigator 1 | ABBVIE INC. | $11,027.00 | 06/03/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder | No dispute reported | 06/30/2026 | 1202489407 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,377.00 | 05/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545857 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 05/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545862 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 05/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545866 |
| Principal investigator 1 | LivaNova USA, Inc. | $452.25 | 05/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545870 |
| Principal investigator 1 | LivaNova USA, Inc. | $452.25 | 05/09/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545883 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,377.00 | 04/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545845 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 04/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545848 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 04/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545853 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 04/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545891 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 04/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545896 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 04/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545901 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 03/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545809 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 03/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545813 |
| Principal investigator 1 | LivaNova USA, Inc. | $452.25 | 03/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545818 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 03/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545905 |
| Principal investigator 1 | LivaNova USA, Inc. | $452.25 | 03/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545910 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 03/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245546091 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 03/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245546096 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 03/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245546101 |
| Principal investigator 1 | LivaNova USA, Inc. | $452.25 | 03/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245546105 |
| Principal investigator 1 | LivaNova USA, Inc. | $430.00 | 02/11/2025 | Non-covered Recipient Entity Advarra, Inc. (Central IRB) | RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression | No dispute reported | 06/30/2026 | 1245556558 |
| Principal investigator 1 | LivaNova USA, Inc. | $430.00 | 02/11/2025 | Non-covered Recipient Entity Advarra, Inc. (Central IRB) | RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression | No dispute reported | 06/30/2026 | 1245556616 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 02/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545756 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,377.00 | 02/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545760 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 02/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545765 |
| Principal investigator 1 | LivaNova USA, Inc. | $452.25 | 02/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545770 |
| Principal investigator 1 | LivaNova USA, Inc. | $519.75 | 02/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545775 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 02/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545806 |
| Principal investigator 1 | Boehringer Ingelheim Pharmaceuticals, Inc. | $9,000.00 | 02/06/2025 | Non-covered Recipient Entity Psych Atlanta, PC | Phase II dose finding trial in monotherapy for MDD | No dispute reported | 06/30/2026 | 1220813301 |
| Principal investigator 1 | E.R. Squibb & Sons, L.L.C. | $53,645.88 | 01/17/2025 | Non-covered Recipient Entity Psych Atlanta | An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia | No dispute reported | 06/30/2026 | 1235994433 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 01/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545740 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,377.00 | 01/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545744 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 01/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545748 |
| Principal investigator 1 | LivaNova USA, Inc. | $452.25 | 01/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545752 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 01/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545788 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 01/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545792 |
| Principal investigator 1 | LivaNova USA, Inc. | $1,512.00 | 01/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545797 |
| Principal investigator 1 | LivaNova USA, Inc. | $101.25 | 01/08/2025 | Non-covered Recipient Entity PSYCH ATLANTA PC | RECOVER | No dispute reported | 06/30/2026 | 1245545801 |
| Principal investigator 1 | E.R. Squibb & Sons, L.L.C. | $15,411.43 | 01/06/2025 | Non-covered Recipient Entity Psych Atlanta | A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia (ARISE) | No dispute reported | 06/30/2026 | 1235994435 |
| Principal investigator 1 | Boehringer Ingelheim International GmbH | $45.00 | 01/01/2025 | Non-covered Recipient Entity Hightop Health-Marietta | Phase II dose finding trial in monotherapy for MDD | No dispute reported | 06/30/2026 | 1220692445 |
| Principal investigator 1 | Boehringer Ingelheim International GmbH | $45.00 | 01/01/2025 | Non-covered Recipient Entity Hightop Health-Marietta | Phase II dose finding trial in monotherapy for MDD | No dispute reported | 06/30/2026 | 1220692447 |
| Principal investigator 1 | Boehringer Ingelheim International GmbH | $73.39 | 01/01/2025 | Non-covered Recipient Entity Hightop Health-Marietta | Phase II dose finding trial in monotherapy for MDD | No dispute reported | 06/30/2026 | 1220692449 |